analyst
SY
NASDAQ · SYRE
Spyre Therapeutics, Inc.
Healthcare · Biotechnology
$91.17
Up+$0.22 (+0.24%)
Updated Sep 17, 2026, 9:24 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.07B
- P/E ratio
- -79.77
- Dividend yield
- 0.00%
- 52-week range
- $39.00 – $110.18
- Volume
- 1.26M
- Avg. volume
- 928.45K
Price performance
SYRE price history
1M range · 20 trading sessions · Daily adjusted prices
SYRE closed at $91.17 after 20 trading sessions, down 16.30% for the selected period.
- Last close
- $91.17
- Period change
- -16.30%
- Period low
- $86.93
- Period high
- $108.92
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $91.38 | $93.065 | $90.48 | $91.17 | 1.26M |
| Sep 15, 2026 | $90.82 | $91.07 | $88.47 | $90.95 | 858.49K |
| Sep 14, 2026 | $90.21 | $91.4025 | $89.43 | $90.80 | 1.1M |
| Sep 11, 2026 | $90.00 | $91.405 | $87.89 | $90.60 | 886.06K |
| Sep 10, 2026 | $85.56 | $88.72 | $85.26 | $88.71 | 902.46K |
| Sep 9, 2026 | $88.07 | $89.57 | $86.85 | $86.93 | 1.01M |
| Sep 8, 2026 | $85.002 | $92.10 | $85.0001 | $90.79 | 1.25M |
| Sep 4, 2026 | $86.45 | $89.18 | $84.68 | $88.98 | 803.86K |
| Sep 3, 2026 | $86.71 | $87.90 | $85.775 | $87.25 | 1.05M |
| Sep 2, 2026 | $88.05 | $90.18 | $84.00 | $87.05 | 1.36M |
| Sep 1, 2026 | $87.06 | $90.00 | $85.00 | $88.50 | 1.43M |
| Aug 31, 2026 | $89.15 | $90.965 | $86.40 | $89.33 | 1.91M |
| Aug 28, 2026 | $91.75 | $93.39 | $89.45 | $90.36 | 1.27M |
| Aug 27, 2026 | $93.61 | $94.945 | $91.25 | $93.615 | 1.17M |
| Aug 26, 2026 | $92.41 | $96.22 | $90.60 | $93.605 | 3.12M |
| Aug 25, 2026 | $109.02 | $110.15 | $106.94 | $107.36 | 923.6K |
| Aug 24, 2026 | $106.49 | $108.02 | $104.94 | $106.65 | 640.58K |
| Aug 21, 2026 | $108.85 | $110.00 | $105.71 | $106.49 | 1.01M |
| Aug 20, 2026 | $106.60 | $108.18 | $104.56 | $107.79 | 700.64K |
| Aug 19, 2026 | $110.00 | $110.175 | $104.17 | $108.92 | 1.17M |
Latest SYRE news
The latest Smart Investors Daily articles mentioning SYRE.
Stock researchCompany · Financials
Loading stock research…